ESC 365 - QT dispersion in patients with myocardial infarction and high-dose therapy with atorvastatin

EHRA Premium Access

QT dispersion in patients with myocardial infarction and high-dose therapy with atorvastatin

Session: Poster session 2 - Arrhythmias

Topic: Treatment

Speaker: Professor V. Oleinikov (Penza, RU)

Event: EHRA 2019

Congress Presentation

About the speaker

Professor Valentin Oleinikov

Penza State University, Penza (Russian Federation)

0 follower

6 more presentations in this session

Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease.

Speaker: Doctor A. Tarasov (Moscow, RU)

Effect of efficient lipid-lowering atorvastatin therapy on heart rate variability in the post-infarction period

Speaker: Professor V. Oleinikov (Penza, RU)

Antiarrhythmic relevance of inhibiting cardiac and non-cardiac sodium channel isoforms for the suppression of torsades de pointes arrhythmias in the chronic av block dog

Speaker: Mr A. Bossu (Utrecht, NL)

Analysis of predictive factors for propafenone proarrythmia. Does exercise ECG play a role during long term propafenone treatment?

Speaker: Mr P. Kalmar (Debrecen, HU)

Venous thrombosis in patients after catheter ablation.Efficacy and safety of enoxaparin therapy with the transition to warfarin and monotherapy with rivaroxaban

Speaker: Miss A. Loginova (Moscow, RU)

Access the full session

Poster session 2 - Arrhythmias

Speakers: Professor V. Oleinikov, Doctor A. Tarasov, Professor V. Oleinikov, Mr A. Bossu, Mr P. Kalmar...

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by